TD Waterhouse Canada’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.4K | Sell |
655
-961
| -59% | -$79.8K | ﹤0.01% | 1102 |
|
|
2025
Q1 | $126K | Sell |
1,616
-1,067
| -40% | -$83.2K | ﹤0.01% | 886 |
|
|
2024
Q4 | $242K | Buy |
2,683
+92
| +4% | +$8.29K | ﹤0.01% | 761 |
|
|
2024
Q3 | $253K | Buy |
2,591
+2,122
| +452% | +$207K | ﹤0.01% | 738 |
|
|
2024
Q2 | $43.7K | Buy |
469
+190
| +68% | +$17.7K | ﹤0.01% | 1050 |
|
|
2024
Q1 | $32.6K | Sell |
279
-539
| -66% | -$63K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $80K | Sell |
818
-22
| -3% | -$2.15K | ﹤0.01% | 847 |
|
|
2023
Q3 | $65.4K | Sell |
840
-201
| -19% | -$15.6K | ﹤0.01% | 862 |
|
|
2023
Q2 | $98K | Sell |
1,041
-1,298
| -55% | -$122K | ﹤0.01% | 792 |
|
|
2023
Q1 | $207K | Buy |
2,339
+203
| +10% | +$18K | ﹤0.01% | 649 |
|
|
2022
Q4 | $206K | Buy |
2,136
+599
| +39% | +$57.9K | ﹤0.01% | 642 |
|
|
2022
Q3 | $148K | Sell |
1,537
-38,163
| -96% | -$3.68M | ﹤0.01% | 709 |
|
|
2022
Q2 | $3.24M | Sell |
39,700
-505
| -1% | -$41.2K | 0.04% | 247 |
|
|
2022
Q1 | $4.7M | Buy |
40,205
+13,607
| +51% | +$1.59M | 0.05% | 219 |
|
|
2021
Q4 | $3.76M | Buy |
+26,598
| New | +$3.76M | 0.04% | 257 |
|